Literature DB >> 9880737

The clinical implications of non-idiopathic intussusception.

R T Blakelock1, S W Beasley.   

Abstract

A pathological lesion can be identified at the leadpoint of intussusception in about 6% of episodes. Occasionally, general manifestations of an underlying disease indicate the specific cause of an intussusception (e.g., perioral pigmentation in Peutz-Jeghers syndrome), but usually the clinical features provide no clues as to the aetiology. Neonatal intussusception may be caused by a duplication cyst or Meckel's diverticulum. Beyond 12 months, the proportion of intussusceptions due to a pathological lesion at the leadpoint increases with age. There is an identifiable lesion in the majority of children over 5 years of age. Postoperative intussusception accounts for between 0.5% and 16% of intussusceptions, although it has a variety of causes; it typically follows retroperitoneal dissection. It is unusual for an intussusception due to a pathological lesion at the leadpoint to be reduced by enema. If it is reduced, the lesion may be seen at the time of reduction or fluoroscopy, or subsequently on ultrasonography.

Entities:  

Mesh:

Year:  1998        PMID: 9880737     DOI: 10.1007/s003830050475

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  19 in total

Review 1.  Intussusception. Part 3: Diagnosis and management of those with an identifiable or predisposing cause and those that reduce spontaneously.

Authors:  Oscar Navarro; Alan Daneman
Journal:  Pediatr Radiol       Date:  2003-10-08

2.  Intussusception in children: lessons learned from intestinal lymphoma as a rare lead-point.

Authors:  H R Bussell; S Kroiss; S J Tharakan; M Meuli; U Moehrlen
Journal:  Pediatr Surg Int       Date:  2019-05-28       Impact factor: 1.827

3.  Intussusception mimicking rectal prolapse.

Authors:  Sarah Tennant; Kath Halliday
Journal:  Pediatr Radiol       Date:  2008-03-08

Review 4.  Intussusception: past, present and future.

Authors:  Emily A Edwards; Nicholas Pigg; Jesse Courtier; Matthew A Zapala; John D MacKenzie; Andrew S Phelps
Journal:  Pediatr Radiol       Date:  2017-08-04

5.  Bowel intussusceptions in adults: the role of imaging.

Authors:  Francesco Somma; Angela Faggian; Nicola Serra; Gianluca Gatta; Francesca Iacobellis; Daniela Berritto; Alfonso Reginelli; Veronica Di Mizio; Salvatore Cappabianca; Roberto Di Mizio; Roberto Grassi
Journal:  Radiol Med       Date:  2014-08-13       Impact factor: 3.469

6.  Reduction of intussusception in infants by a pediatric surgical team: improvement in safety and outcome.

Authors:  Tadaharu Okazaki; Yuki Ogasawara; Nana Nakazawa; Hiroyuki Kobayashi; Yoshifumi Kato; Geoffrey J Lane; Atsuyuki Yamataka; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

7.  Intussusception in infants younger than 3 months: a single center's experience.

Authors:  Fei-Teng Kong; Wen-Ying Liu; Yun-Man Tang; Lin Zhong; Xue-Jun Wang; Gang Yang; Hou-Ping Chen
Journal:  World J Pediatr       Date:  2010-02-09       Impact factor: 2.764

8.  Risk factors for pediatric intussusception complicated by loss of intestine viability in China from June 2009 to May 2014: a retrospective study.

Authors:  Xian-Ming Yao; Zhong-Liang Chen; De-Lei Shen; Qi-Shuang Zhou; Song-Song Huang; Zu-Ren Cai; Yu-Long Tong; Meng Wang; Yi Ren; Xin-He Lai; Xiao-Ming Chen
Journal:  Pediatr Surg Int       Date:  2014-12-19       Impact factor: 1.827

9.  Clinical characteristics of intussusception secondary to pathologic lead points in children: a single-center experience with 65 cases.

Authors:  Xiao-Kun Lin; Qiong-Zhang Xia; Xiao-Zhong Huang; Yi-Jiang Han; Guo-Rong He; Na Zheng
Journal:  Pediatr Surg Int       Date:  2017-06-05       Impact factor: 1.827

10.  Ultrasound-guided Hartmann's solution enema: first-choice procedure for reducing idiopathic intussusception.

Authors:  D Di Renzo; M Colangelo; G Lauriti; F De Girolamo; A Persico; P Lelli Chiesa
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.